Looks like a lot of lipstick was applied to this PR. Even with bloom-dm as the red text in the pr indicates, a potential approval could only be for obese diabetic people. then ARNA has to prove there is no cancer risk and what's it going to take for that. The only positive i can see is that eisai appears to be standing behind the drug which is surprising, to me at least.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.